Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1348-1349, 2011-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The prasugrel new drug application (NDA) is still under discussion with the US FDA
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
Access to resources
Recommend
The US Government Accountability Office is to review a drug approval process used by the FDA
Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. :
US FDA addresses postmarketing drug surveillance concerns
Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. :
Update on the Office of Drug Safety at the US FDA
Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. :
US FDA reports new steps in drug safety
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :